Riskpilot← Back to searchSign inGet full accessCEPHALON FINLAND A/S
A/SActiveCVR 29245037Sundsholmen 29Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20061 employees
Revenue 2025
DKK 7,1M
+78% vs 2024
EBITDA margin
36.9%
+707% vs 2024
Equity ratio
55.4%
Financial strength
Net profit 2025
DKK 2,1M
+594% vs 2024
| Revenue | DKK 7,1M | +78% |
| EBITDA | DKK 2,6M | +707% |
| Net profit | DKK 2,1M | +594% |
| Total assets | DKK 13M | +59% |
| Equity | DKK 7,2M | +34% |
| Employees | 1 | — |
Legal name
CEPHALON FINLAND A/S
CVR number
29245037
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13. januar 2006
Share capital
DKK 500.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand og et bestyrelses medlem tilsammen eller af direktøren alene.
Company purpose
Selskabets formål er at drive virksomhed med handel samt hermed efter bestyrelsens skøn beslægtet virksomhed.
Address
Sundsholmen 29
Phone
+4596320600
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5.772 | 6.993 | 4.166 | 3.970 | 7.079 |
| Staff expenses | -4.021 | -4.308 | -3.587 | -3.647 | -4.469 |
| EBITDA | 1.751 | 2.686 | 579 | 323 | 2.609 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 1.751 | 2.686 | 579 | 323 | 2.609 |
| Net financials | -29 | 84 | -63 | 54 | 26 |
| Profit before tax | 1.722 | 2.770 | 674 | 377 | 2.636 |
| Tax | 389 | 616 | 153 | 80 | 576 |
| Net profit | 1.334 | 2.154 | 521 | 297 | 2.059 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 10.614 | 10.261 | 7.977 | 8.176 | 12.983 |
| Equity | 6.012 | 6.866 | 5.087 | 5.384 | 7.193 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4.602 | 3.394 | 2.890 | 2.792 | 5.790 |
| Total debt | 4.602 | 3.394 | 2.890 | 2.792 | 5.790 |
EBITDA margin
36.9%
This company
15.8%
Market median
+134% vs market
20212025
Equity ratio
55.4%
This company
38.2%
Market median
+45% vs market
20212025
Return on equity
28.6%
This company
18.4%
Market median
+55% vs market
20212025
Net profit margin
29.1%
This company
8.1%
Market median
+259% vs market
20212025
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
20212025
Debt / equity
0.80×
This company
0.62×
Market median
+29% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RN Chief Executive Officer | Chief Executive Officer | 2013 |
| Former (1) | ||
KE Management | Management | 2006 – 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2013 | |
| Former (2) | ||
| Board of Directors | 2014 – 2016 | |
| Board of Directors | 2006 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2023 | |
| Individual | 15–19.99% | 15–19.99% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CEPHALON FINLAND A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Klaus Erik Johansen | Management | 0 companies |
| Rolf Nejsum | Chief Executive Officer | 0 companies |
| Vesa Antero Toropainen | Board of Directors | 0 companies |
| Jani Penttinen | Board of Directors | 0 companies |
| Bjørn Helmer Johnsen | Chairman | 0 companies |
| Lauri Esko Ilmari Laaksonen | Board of Directors | 0 companies |